| |
|
|
|
Eiger Biopharma  
|
|
9.2 0.45 (0.05%) |
11-27 13:00 |
|
Open: |
8.84 |
Pre close: |
8.75 |
Target:
|
11.86
|
|
High: |
9.31 |
Low: |
8.7 |
Resistance:
|
10.16
11.13
|
|
Volume: |
270,010 |
Market Cap: |
299M |
Support:
|
8.58
7.14
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
9.31
 |
MACD |
MACD(12,26):
|
-0.03 |
|
MA(20): |
9.77  |
Signal(12,26,9): |
0.13 |
|
MA(100): |
10.02 |
Stochastic Oscillator |
%K(14,3):
|
12.17 |
|
MA(250): |
10.40 |
%D(3): |
20.11 |
|
Average Volume(K) |
3-Month: |
55217
|
52-Week |
High:
|
15.82 |
|
10-Days: |
82365 |
Low: |
4.55 |
|
RSI |
RSI(14):
|
44.88 |
Change(%): |
-29.2 |
|
Financials, Statistics and Valuation |
|
EPS |
-2.420 |
Return on Equity (ttm) |
-76.8 |
Shares Out. (M) |
32.53 |
|
EPS Est. Current Year |
-5.200 |
Return on Assets (ttm) |
-29.1 |
Shares Float (M) |
26.52 |
|
EPS Est. Next Year |
-4.860 |
PEG Ratio |
0.00 |
% Held by Insiders |
1.27 |
|
EPS Est. Next Quarter |
-1.310 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
67.91 |
|
Forward EPS |
-3.080 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
1500 |
|
Book Value (p.s.) |
2.910 |
EBITDA (p.s.) |
-1.862 |
P/E |
-3.80 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
3.16 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-62.64 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-40.05 |
P/CF |
-4.78 |
|
|
|
|
|
|
